Park, A. Y. Et Al. 2024. GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway. Nature Immunology , vol.25, no.2 , 282-293.

Park, A. Y., Leney-Greene, M., Lynberg, M., Gabrielski, J. Q., Xu, X., Schwarz, B., ... Zheng, L.(2024). GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway. Nature Immunology , vol.25, no.2, 282-293.

Park, Ann Et Al. "GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway," Nature Immunology , vol.25, no.2, 282-293, 2024

Park, Ann Y. Et Al. "GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway." Nature Immunology , vol.25, no.2, pp.282-293, 2024

Park, A. Y. Et Al. (2024) . "GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway." Nature Immunology , vol.25, no.2, pp.282-293.

@article{article, author={Ann Y. Park Et Al. }, title={GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway}, journal={Nature Immunology}, year=2024, pages={282-293} }